Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.
Identifieur interne : 000588 ( PubMed/Curation ); précédent : 000587; suivant : 000589Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.
Auteurs : Gavin J. Churchyard [Afrique du Sud] ; Katherine L. Fielding ; James J. Lewis ; Violet N. Chihota ; Yasmeen Hanifa ; Alison D. GrantSource :
- AIDS (London, England) [ 1473-5571 ] ; 2010.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Antituberculeux (usage thérapeutique), Dépistage systématique, Enquêtes et questionnaires, Femelle, Humains, Infections opportunistes liées au SIDA (imagerie diagnostique), Infections opportunistes liées au SIDA (traitement médicamenteux), Infections opportunistes liées au SIDA (épidémiologie), Infections à VIH (imagerie diagnostique), Infections à VIH (traitement médicamenteux), Infections à VIH (épidémiologie), Isoniazide (usage thérapeutique), Mycobacterium tuberculosis (isolement et purification), Mâle, Prévalence, Radiographie thoracique, Tuberculose pulmonaire (épidémiologie).
- MESH :
- imagerie diagnostique : Infections opportunistes liées au SIDA, Infections à VIH.
- isolement et purification : Mycobacterium tuberculosis.
- traitement médicamenteux : Infections opportunistes liées au SIDA, Infections à VIH.
- usage thérapeutique : Antituberculeux, Isoniazide.
- épidémiologie : Infections opportunistes liées au SIDA, Infections à VIH, Tuberculose pulmonaire.
- Adulte, Adulte d'âge moyen, Dépistage systématique, Enquêtes et questionnaires, Femelle, Humains, Mâle, Prévalence, Radiographie thoracique.
English descriptors
- KwdEn :
- AIDS-Related Opportunistic Infections (diagnostic imaging), AIDS-Related Opportunistic Infections (drug therapy), AIDS-Related Opportunistic Infections (epidemiology), Adult, Antitubercular Agents (therapeutic use), Female, HIV Infections (diagnostic imaging), HIV Infections (drug therapy), HIV Infections (epidemiology), Humans, Isoniazid (therapeutic use), Male, Mass Screening, Middle Aged, Mycobacterium tuberculosis (isolation & purification), Prevalence, Radiography, Thoracic, Surveys and Questionnaires, Tuberculosis, Pulmonary (epidemiology).
- MESH :
- chemical , therapeutic use : Antitubercular Agents, Isoniazid.
- diagnostic imaging : AIDS-Related Opportunistic Infections, HIV Infections.
- drug therapy : AIDS-Related Opportunistic Infections, HIV Infections.
- epidemiology : AIDS-Related Opportunistic Infections, HIV Infections, Tuberculosis, Pulmonary.
- isolation & purification : Mycobacterium tuberculosis.
- Adult, Female, Humans, Male, Mass Screening, Middle Aged, Prevalence, Radiography, Thoracic, Surveys and Questionnaires.
Abstract
This analysis describes the prevalence of and risk factors for tuberculosis at screening prior to isoniazid preventive therapy (IPT); the additional yield of tuberculosis using chest radiography versus symptoms alone, and risk factors for tuberculosis missed by screening.
DOI: 10.1097/01.aids.0000391018.72542.46
PubMed: 21079424
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000588
Links to Exploration step
pubmed:21079424Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.</title><author><name sortKey="Churchyard, Gavin J" sort="Churchyard, Gavin J" uniqKey="Churchyard G" first="Gavin J" last="Churchyard">Gavin J. Churchyard</name><affiliation wicri:level="1"><nlm:affiliation>Aurum Institute for Health Research, Johannesburg, South Africa. gchurchyard@auruminstitute.org</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Aurum Institute for Health Research, Johannesburg</wicri:regionArea></affiliation></author><author><name sortKey="Fielding, Katherine L" sort="Fielding, Katherine L" uniqKey="Fielding K" first="Katherine L" last="Fielding">Katherine L. Fielding</name></author><author><name sortKey="Lewis, James J" sort="Lewis, James J" uniqKey="Lewis J" first="James J" last="Lewis">James J. Lewis</name></author><author><name sortKey="Chihota, Violet N" sort="Chihota, Violet N" uniqKey="Chihota V" first="Violet N" last="Chihota">Violet N. Chihota</name></author><author><name sortKey="Hanifa, Yasmeen" sort="Hanifa, Yasmeen" uniqKey="Hanifa Y" first="Yasmeen" last="Hanifa">Yasmeen Hanifa</name></author><author><name sortKey="Grant, Alison D" sort="Grant, Alison D" uniqKey="Grant A" first="Alison D" last="Grant">Alison D. Grant</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:21079424</idno><idno type="pmid">21079424</idno><idno type="doi">10.1097/01.aids.0000391018.72542.46</idno><idno type="wicri:Area/PubMed/Corpus">000588</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000588</idno><idno type="wicri:Area/PubMed/Curation">000588</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000588</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.</title><author><name sortKey="Churchyard, Gavin J" sort="Churchyard, Gavin J" uniqKey="Churchyard G" first="Gavin J" last="Churchyard">Gavin J. Churchyard</name><affiliation wicri:level="1"><nlm:affiliation>Aurum Institute for Health Research, Johannesburg, South Africa. gchurchyard@auruminstitute.org</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Aurum Institute for Health Research, Johannesburg</wicri:regionArea></affiliation></author><author><name sortKey="Fielding, Katherine L" sort="Fielding, Katherine L" uniqKey="Fielding K" first="Katherine L" last="Fielding">Katherine L. Fielding</name></author><author><name sortKey="Lewis, James J" sort="Lewis, James J" uniqKey="Lewis J" first="James J" last="Lewis">James J. Lewis</name></author><author><name sortKey="Chihota, Violet N" sort="Chihota, Violet N" uniqKey="Chihota V" first="Violet N" last="Chihota">Violet N. Chihota</name></author><author><name sortKey="Hanifa, Yasmeen" sort="Hanifa, Yasmeen" uniqKey="Hanifa Y" first="Yasmeen" last="Hanifa">Yasmeen Hanifa</name></author><author><name sortKey="Grant, Alison D" sort="Grant, Alison D" uniqKey="Grant A" first="Alison D" last="Grant">Alison D. Grant</name></author></analytic><series><title level="j">AIDS (London, England)</title><idno type="eISSN">1473-5571</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Opportunistic Infections (diagnostic imaging)</term><term>AIDS-Related Opportunistic Infections (drug therapy)</term><term>AIDS-Related Opportunistic Infections (epidemiology)</term><term>Adult</term><term>Antitubercular Agents (therapeutic use)</term><term>Female</term><term>HIV Infections (diagnostic imaging)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (epidemiology)</term><term>Humans</term><term>Isoniazid (therapeutic use)</term><term>Male</term><term>Mass Screening</term><term>Middle Aged</term><term>Mycobacterium tuberculosis (isolation & purification)</term><term>Prevalence</term><term>Radiography, Thoracic</term><term>Surveys and Questionnaires</term><term>Tuberculosis, Pulmonary (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Antituberculeux (usage thérapeutique)</term><term>Dépistage systématique</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Infections opportunistes liées au SIDA (imagerie diagnostique)</term><term>Infections opportunistes liées au SIDA (traitement médicamenteux)</term><term>Infections opportunistes liées au SIDA (épidémiologie)</term><term>Infections à VIH (imagerie diagnostique)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Infections à VIH (épidémiologie)</term><term>Isoniazide (usage thérapeutique)</term><term>Mycobacterium tuberculosis (isolement et purification)</term><term>Mâle</term><term>Prévalence</term><term>Radiographie thoracique</term><term>Tuberculose pulmonaire (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antitubercular Agents</term><term>Isoniazid</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>AIDS-Related Opportunistic Infections</term><term>HIV Infections</term><term>Tuberculosis, Pulmonary</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Mycobacterium tuberculosis</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Mycobacterium tuberculosis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antituberculeux</term><term>Isoniazide</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections opportunistes liées au SIDA</term><term>Infections à VIH</term><term>Tuberculose pulmonaire</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Middle Aged</term><term>Prevalence</term><term>Radiography, Thoracic</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Dépistage systématique</term><term>Enquêtes et questionnaires</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Prévalence</term><term>Radiographie thoracique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This analysis describes the prevalence of and risk factors for tuberculosis at screening prior to isoniazid preventive therapy (IPT); the additional yield of tuberculosis using chest radiography versus symptoms alone, and risk factors for tuberculosis missed by screening.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21079424</PMID><DateCreated><Year>2010</Year><Month>11</Month><Day>16</Day></DateCreated><DateCompleted><Year>2011</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2017</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5571</ISSN><JournalIssue CitedMedium="Internet"><Volume>24 Suppl 5</Volume><PubDate><Year>2010</Year><Month>Nov</Month></PubDate></JournalIssue><Title>AIDS (London, England)</Title><ISOAbbreviation>AIDS</ISOAbbreviation></Journal><ArticleTitle>Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.</ArticleTitle><Pagination><MedlinePgn>S19-27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/01.aids.0000391018.72542.46</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This analysis describes the prevalence of and risk factors for tuberculosis at screening prior to isoniazid preventive therapy (IPT); the additional yield of tuberculosis using chest radiography versus symptoms alone, and risk factors for tuberculosis missed by screening.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cross-sectional analysis of a trial of community-wide IPT in South African gold mines.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Participants were screened for tuberculosis prior to starting IPT using symptoms (cough >2 weeks, weight loss, night sweats) and chest radiography. Tuberculosis suspects had sputum collected for mycobacterial investigations. Those with a positive smear or culture with no speciation or culture identified as Mycobacterium tuberculosis were classified as having probable or definite tuberculosis, respectively. Among participants who were dispensed IPT, we defined a 'missed' case of active tuberculosis as one identified within 90 days of the enrolment screen.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between July 2006 and December 2008, among 23,286 participants with complete data, the prevalence of undiagnosed tuberculosis [definite (284) and probable (31)] was high (315/23 286; 1.4%). The addition of chest radiography to symptom screening increased the number of definite tuberculosis cases detected by 2.5-fold (113 to 281 cases). Among 19,609 individuals correctly screened for tuberculosis who started IPT and had more than 90 days of follow-up, only 39 (0.2%) active tuberculosis cases were missed. Risk factors for tuberculosis missed by screening included increasing age [adjusted odds ratio (aOR) 1.66/10 year increase, 95% confidence interval (CI) 1.07-2.56], non-South African, in HIV care (aOR 4.80, 95% CI 1.63-14.1), lower weight (aOR 2.07/10 kg decrease, 95% CI 1.23-3.49) and alcohol use (aOR 2.52, 95% CI 1.31-4.86), which were similar to risk factors for tuberculosis detected by screening.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Tuberculosis screening prior to IPT detects a substantial burden of tuberculosis and misses very few cases. Chest radiography significantly increased the yield of tuberculosis cases detected.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Churchyard</LastName><ForeName>Gavin J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Aurum Institute for Health Research, Johannesburg, South Africa. gchurchyard@auruminstitute.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fielding</LastName><ForeName>Katherine L</ForeName><Initials>KL</Initials></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>James J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Chihota</LastName><ForeName>Violet N</ForeName><Initials>VN</Initials></Author><Author ValidYN="Y"><LastName>Hanifa</LastName><ForeName>Yasmeen</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Grant</LastName><ForeName>Alison D</ForeName><Initials>AD</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G0700837</GrantID><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>AI077486</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>AIDS</MedlineTA><NlmUniqueID>8710219</NlmUniqueID><ISSNLinking>0269-9370</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000995">Antitubercular Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>V83O1VOZ8L</RegistryNumber><NameOfSubstance UI="D007538">Isoniazid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017088" MajorTopicYN="N">AIDS-Related Opportunistic Infections</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000995" MajorTopicYN="N">Antitubercular Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007538" MajorTopicYN="N">Isoniazid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013902" MajorTopicYN="N">Radiography, Thoracic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014397" MajorTopicYN="N">Tuberculosis, Pulmonary</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21079424</ArticleId><ArticleId IdType="doi">10.1097/01.aids.0000391018.72542.46</ArticleId><ArticleId IdType="pii">00002030-201011005-00004</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000588 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000588 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:21079424
|texte= Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:21079424" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |